Evidence map›Paper›PMID 33234710›Full record

ArticleDisease models & mechanisms2020

Impaired muscle morphology in a

Martin Dahl-Halvarsson, Montse Olive, Malgorzata Pokrzywa, Michaela Norum, Katarina Ejeskär, Homa Tajsharghi

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Martin Dahl-HalvarssonDepartment of Pathology, Institute of Biomedicine, University of Gothenburg, 41345 Gothenburg, Sweden.ORCID 0000-0003-4312-0363
Montse OliveInstitute of Neuropathology, Department of Pathology and Neuromuscular Unit, Department of Neurology, IDIBELL-Hospital de Bellvitge, 08907 Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0001-5727-0165
Malgorzata PokrzywaDepartment of Pathology, Institute of Biomedicine, University of Gothenburg, 41345 Gothenburg, Sweden.ORCID 0000-0002-6791-4160
Michaela NorumDepartment of Pathology, Institute of Biomedicine, University of Gothenburg, 41345 Gothenburg, Sweden.ORCID 0000-0002-5669-4801
Katarina EjeskärTranslational Medicine, School of Health Sciences, University of Skövde, SE-541 28, Skövde, Sweden.
Homa TajsharghiTranslational Medicine, School of Health Sciences, University of Skövde, SE-541 28, Skövde, Sweden homa.tajsharghi@his.se.ORCID 0000-0001-8854-5213
University of Gothenburg · SEUniversity of Skövde · SEBellvitge University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myosin is vital for body movement and heart contractility. Mutations in

Indexed as

AnimalsAnimals, Genetically ModifiedDisease Models, AnimalDrosophila melanogasterDrosophila ProteinsLongevityMovementMuscle, SkeletalMuscular DiseasesMuscular Dystrophy, Emery-DreifussMutationMyosin Heavy ChainsTime FactorsTripartite Motif ProteinsUbiquitin-Protein LigasesDrosophila ProteinsMyosin Heavy Chainstn protein, DrosophilaTripartite Motif ProteinsUbiquitin-Protein LigasesDrosophila modelE3 ubiquitin ligaseMYH7Myosin storage myopathyPotential therapeutic approachSlow/β-cardiac myosin heavy chainUbiquitin proteasome system

Identifiers

PMID33234710
PMCPMC7790189
OpenAlexW3107383980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.